Literature DB >> 27292646

RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming.

Cheng-Xu Delon Toh1, Jun-Wei Chan2, Zheng-Shan Chong2, Hao Fei Wang3, Hong Chao Guo4, Sandeep Satapathy2, Dongrui Ma5, Germaine Yen Lin Goh6, Ekta Khattar7, Lin Yang8, Vinay Tergaonkar9, Young-Tae Chang10, James J Collins11, George Q Daley12, Keng Boon Wee13, Chadi A El Farran3, Hu Li14, Yoon-Pin Lim15, Frederic A Bard16, Yuin-Han Loh17.   

Abstract

Incomplete knowledge of the mechanisms at work continues to hamper efforts to maximize reprogramming efficiency. Here, we present a systematic genome-wide RNAi screen to determine the global regulators during the early stages of human reprogramming. Our screen identifies functional repressors and effectors that act to impede or promote the reprogramming process. Repressors and effectors form close interacting networks in pathways, including RNA processing, G protein signaling, protein ubiquitination, and chromatin modification. Combinatorial knockdown of five repressors (SMAD3, ZMYM2, SFRS11, SAE1, and ESET) synergistically resulted in ∼85% TRA-1-60-positive cells. Removal of the novel splicing factor SFRS11 during reprogramming is accompanied by rapid acquisition of pluripotency-specific spliced forms. Mechanistically, SFRS11 regulates exon skipping and mutually exclusive splicing of transcripts in genes involved in cell differentiation, mRNA splicing, and chromatin modification. Our study provides insights into the reprogramming process, which comprises comprehensive and multi-layered transcriptional, splicing, and epigenetic machineries.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SFRS11; ZNF207; genome-wide siRNA screen; human somatic cell reprogramming; reprogramming specific alternative splicing

Mesh:

Substances:

Year:  2016        PMID: 27292646     DOI: 10.1016/j.celrep.2016.05.049

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  24 in total

1.  mRNA 5' ends targeted by cytoplasmic recapping cluster at CAGE tags and select transcripts are alternatively spliced.

Authors:  Mikaela R Berger; Rolando Alvarado; Daniel L Kiss
Journal:  FEBS Lett       Date:  2019-03-09       Impact factor: 4.124

2.  Alterations of RNA splicing patterns in esophagus squamous cell carcinoma.

Authors:  Jiyu Ding; Chunquan Li; Yinwei Cheng; Zepeng Du; Qiuyu Wang; Zhidong Tang; Chao Song; Qiaoxi Xia; Wenjing Bai; Ling Lin; Wei Liu; Liyan Xu; Enmin Li; Bingli Wu
Journal:  Cell Biosci       Date:  2021-02-09       Impact factor: 7.133

Review 3.  Mammalian synthetic biology in the age of genome editing and personalized medicine.

Authors:  Patrick Ho; Yvonne Y Chen
Journal:  Curr Opin Chem Biol       Date:  2017-06-16       Impact factor: 8.822

4.  Genomic and Proteomic Resolution of Heterochromatin and Its Restriction of Alternate Fate Genes.

Authors:  Justin S Becker; Ryan L McCarthy; Simone Sidoli; Greg Donahue; Kelsey E Kaeding; Zhiying He; Shu Lin; Benjamin A Garcia; Kenneth S Zaret
Journal:  Mol Cell       Date:  2017-12-21       Impact factor: 17.970

Review 5.  Decoding pluripotency: Genetic screens to interrogate the acquisition, maintenance, and exit of pluripotency.

Authors:  Qing V Li; Bess P Rosen; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-08-13

Review 6.  Arrayed functional genetic screenings in pluripotency reprogramming and differentiation.

Authors:  Rodrigo Alexandre Panepucci; Ildercílio Mota de Souza Lima
Journal:  Stem Cell Res Ther       Date:  2019-01-11       Impact factor: 6.832

7.  Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.

Authors:  Rupert L Mayer; Josef D Schwarzmeier; Marlene C Gerner; Andrea Bileck; Johanna C Mader; Samuel M Meier-Menches; Samuel M Gerner; Klaus G Schmetterer; Tobias Pukrop; Albrecht Reichle; Astrid Slany; Christopher Gerner
Journal:  Mol Cell Proteomics       Date:  2017-12-01       Impact factor: 5.911

8.  Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1.

Authors:  Claudia Vivori; Panagiotis Papasaikas; Ralph Stadhouders; Bruno Di Stefano; Anna Ribó Rubio; Clara Berenguer Balaguer; Serena Generoso; Anna Mallol; José Luis Sardina; Bernhard Payer; Thomas Graf; Juan Valcárcel
Journal:  Genome Biol       Date:  2021-06-03       Impact factor: 17.906

9.  Alternative splicing is a developmental switch for hTERT expression.

Authors:  Alex Penev; Andrew Bazley; Michael Shen; Jef D Boeke; Sharon A Savage; Agnel Sfeir
Journal:  Mol Cell       Date:  2021-04-13       Impact factor: 19.328

Review 10.  EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.

Authors:  Davide Pradella; Chiara Naro; Claudio Sette; Claudia Ghigna
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.